Novel, broad spectrum anticancer agents containing the tricyclic 5: 7:5-fused diimidazodiazepine ring system

Atul Kondaskar, Shilpi Kondaskar, Raj Kumar, James C. Fishbein, Nidal Muvarak, Rena G. Lapidus, Mariola Sadowska, Martin J. Edelman, Guus M. Bol, Farhad Vesuna, Venu Raman, Ramachandra S. Hosmane

Research output: Contribution to journalArticle

Abstract

Synthesis of a series of novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepine ring system is reported. Compounds 1, 2, 8, 11, and 12 in the series show promising in vitro antitumor activity with low micromolar IC50 values against prostate, lung, breast, and ovarian cancer cell lines. Some notions about structure-activity relationships and a possible mechanism of biological activity are presented. Also presented are preliminary in vivo toxicity studies of 1 using SCID mice.

Original languageEnglish (US)
Pages (from-to)252-256
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume2
Issue number3
DOIs
StatePublished - Mar 10 2011

Fingerprint

SCID Mice
Structure-Activity Relationship
Bioactivity
Antineoplastic Agents
Ovarian Neoplasms
Inhibitory Concentration 50
Toxicity
Lung Neoplasms
Prostatic Neoplasms
Cells
Breast Neoplasms
Cell Line
8-1 compound
In Vitro Techniques

Keywords

  • 5:7:5-fused tricycles
  • and ovarian cancers
  • breast
  • broad spectrum anticancer activity
  • diimidazo[4,5-d:4′,5′-f][1,3] diazepine ring system
  • effects on G1 and S phases of the cell cycle
  • in vitro screening
  • lung
  • preliminary mechanistic studies
  • prostate
  • Synthesis

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Kondaskar, A., Kondaskar, S., Kumar, R., Fishbein, J. C., Muvarak, N., Lapidus, R. G., ... Hosmane, R. S. (2011). Novel, broad spectrum anticancer agents containing the tricyclic 5: 7:5-fused diimidazodiazepine ring system. ACS Medicinal Chemistry Letters, 2(3), 252-256. https://doi.org/10.1021/ml100281b

Novel, broad spectrum anticancer agents containing the tricyclic 5 : 7:5-fused diimidazodiazepine ring system. / Kondaskar, Atul; Kondaskar, Shilpi; Kumar, Raj; Fishbein, James C.; Muvarak, Nidal; Lapidus, Rena G.; Sadowska, Mariola; Edelman, Martin J.; Bol, Guus M.; Vesuna, Farhad; Raman, Venu; Hosmane, Ramachandra S.

In: ACS Medicinal Chemistry Letters, Vol. 2, No. 3, 10.03.2011, p. 252-256.

Research output: Contribution to journalArticle

Kondaskar, A, Kondaskar, S, Kumar, R, Fishbein, JC, Muvarak, N, Lapidus, RG, Sadowska, M, Edelman, MJ, Bol, GM, Vesuna, F, Raman, V & Hosmane, RS 2011, 'Novel, broad spectrum anticancer agents containing the tricyclic 5: 7:5-fused diimidazodiazepine ring system', ACS Medicinal Chemistry Letters, vol. 2, no. 3, pp. 252-256. https://doi.org/10.1021/ml100281b
Kondaskar, Atul ; Kondaskar, Shilpi ; Kumar, Raj ; Fishbein, James C. ; Muvarak, Nidal ; Lapidus, Rena G. ; Sadowska, Mariola ; Edelman, Martin J. ; Bol, Guus M. ; Vesuna, Farhad ; Raman, Venu ; Hosmane, Ramachandra S. / Novel, broad spectrum anticancer agents containing the tricyclic 5 : 7:5-fused diimidazodiazepine ring system. In: ACS Medicinal Chemistry Letters. 2011 ; Vol. 2, No. 3. pp. 252-256.
@article{0aec6cd97eb74b42a5f10b30e34a6e05,
title = "Novel, broad spectrum anticancer agents containing the tricyclic 5: 7:5-fused diimidazodiazepine ring system",
abstract = "Synthesis of a series of novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepine ring system is reported. Compounds 1, 2, 8, 11, and 12 in the series show promising in vitro antitumor activity with low micromolar IC50 values against prostate, lung, breast, and ovarian cancer cell lines. Some notions about structure-activity relationships and a possible mechanism of biological activity are presented. Also presented are preliminary in vivo toxicity studies of 1 using SCID mice.",
keywords = "5:7:5-fused tricycles, and ovarian cancers, breast, broad spectrum anticancer activity, diimidazo[4,5-d:4′,5′-f][1,3] diazepine ring system, effects on G1 and S phases of the cell cycle, in vitro screening, lung, preliminary mechanistic studies, prostate, Synthesis",
author = "Atul Kondaskar and Shilpi Kondaskar and Raj Kumar and Fishbein, {James C.} and Nidal Muvarak and Lapidus, {Rena G.} and Mariola Sadowska and Edelman, {Martin J.} and Bol, {Guus M.} and Farhad Vesuna and Venu Raman and Hosmane, {Ramachandra S.}",
year = "2011",
month = "3",
day = "10",
doi = "10.1021/ml100281b",
language = "English (US)",
volume = "2",
pages = "252--256",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Novel, broad spectrum anticancer agents containing the tricyclic 5

T2 - 7:5-fused diimidazodiazepine ring system

AU - Kondaskar, Atul

AU - Kondaskar, Shilpi

AU - Kumar, Raj

AU - Fishbein, James C.

AU - Muvarak, Nidal

AU - Lapidus, Rena G.

AU - Sadowska, Mariola

AU - Edelman, Martin J.

AU - Bol, Guus M.

AU - Vesuna, Farhad

AU - Raman, Venu

AU - Hosmane, Ramachandra S.

PY - 2011/3/10

Y1 - 2011/3/10

N2 - Synthesis of a series of novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepine ring system is reported. Compounds 1, 2, 8, 11, and 12 in the series show promising in vitro antitumor activity with low micromolar IC50 values against prostate, lung, breast, and ovarian cancer cell lines. Some notions about structure-activity relationships and a possible mechanism of biological activity are presented. Also presented are preliminary in vivo toxicity studies of 1 using SCID mice.

AB - Synthesis of a series of novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepine ring system is reported. Compounds 1, 2, 8, 11, and 12 in the series show promising in vitro antitumor activity with low micromolar IC50 values against prostate, lung, breast, and ovarian cancer cell lines. Some notions about structure-activity relationships and a possible mechanism of biological activity are presented. Also presented are preliminary in vivo toxicity studies of 1 using SCID mice.

KW - 5:7:5-fused tricycles

KW - and ovarian cancers

KW - breast

KW - broad spectrum anticancer activity

KW - diimidazo[4,5-d:4′,5′-f][1,3] diazepine ring system

KW - effects on G1 and S phases of the cell cycle

KW - in vitro screening

KW - lung

KW - preliminary mechanistic studies

KW - prostate

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=79952649904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952649904&partnerID=8YFLogxK

U2 - 10.1021/ml100281b

DO - 10.1021/ml100281b

M3 - Article

C2 - 21572541

AN - SCOPUS:79952649904

VL - 2

SP - 252

EP - 256

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 3

ER -